XBP1 and metabolic dysfunction-associated steatohepatitis: Altogether, the upregulation of lncRNAs NONMMUT010685 and NONMMUT050689 in NAFLD downregulates XBP1 and RIPK1 and consequently increases ACYL enzyme and progresses development of NASH.